Simlow Cancer Hospitalat Yale-New Haven — New Haven, Connecticut

Simlow Cancer Hospitalat Yale-New Haven is a clinical research site located in New Haven, Connecticut, United States 06510.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

Simlow Cancer Hospitalat Yale-New Haven has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Colorectal Neoplasms, Carcinoma, Non-Small-Cell Lung, Exocrine Pancreatic Cancer.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer.

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Simlow Cancer Hospitalat Yale-New Haven?

Simlow Cancer Hospitalat Yale-New Haven has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Simlow Cancer Hospitalat Yale-New Haven conducted?

Simlow Cancer Hospitalat Yale-New Haven has 1 clinical trials on record, with 1 currently active. Their work covers Colorectal Neoplasms, Carcinoma, Non-Small-Cell Lung, Exocrine Pancreatic Cancer.

Is Simlow Cancer Hospitalat Yale-New Haven accredited by Crixeo Health?

Simlow Cancer Hospitalat Yale-New Haven has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Simlow Cancer Hospitalat Yale-New Haven?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.